Target intelligence / Profile preview

Corneal extracellular matrix

Molecular classification
Other
01

Overview

The **corneal extracellular matrix** is a specialized structure comprising various collagens (primarily type I, V, VI, and XII) and proteoglycans (e.g., keratocan, lumican, decorin, mimecan) that are essential for maintaining corneal transparency, biomechanical strength, and facilitating the passage of light to the retina[1][3]. It forms more than 90% of the corneal thickness and serves as the scaffold for corneal cells, especially keratocytes, which are responsible for continual ECM remodeling during homeostasis and repair. In response to injury or disease, keratocytes become activated and modify the ECM composition, but excessive or disorganized ECM deposition leads to corneal scarring and opacity. Current regenerative therapies focus on using stem cells, bioengineered hydrogels, and decellularized ECM materials to promote proper ECM regeneration, restore clarity, and support nerve and cellular in-growth[1][2][3][4]. "Corneal extracellular matrix regeneration" describes this reparative process, not a discrete target entity.

Other names
Corneal ECMCorneal matrixCorneal stromal matrix
02

Biological functions

Structural supportMaintenance of corneal transparencyTissue repairCell signaling scaffoldRegulation of cell proliferation and differentiation
03

Disease associations

Corneal scarringCorneal dystrophyCorneal opacityBlindness (corneal origin)Wound healing disorders
04

Safety considerations

Immunogenicity of xenogeneic or allogeneic ECM implantsScar formation causing loss of transparencyRisk of infection in tissue-derived productsVariable integration with host tissue[4]
05

Biomarkers

Collagen type I, V, VI, and XIIKeratocanLumicanDecorinMimecanAlpha smooth muscle actin (αSMA)Tenascin-CFibronectinFibrillin-1Ki67 (proliferation marker in regenerative studies)[1][3][4]

Beyond the preview

Go deeper on Corneal extracellular matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal extracellular matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call